The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Immune surveillance against a solid tumor fails because of immunological ignorance
Open accessAbstract
Many peripheral solid tumors such as sarcomas and carcinomas express tumor-specific antigens that can serve as targets for immune effector T cells. Nevertheless, overall immune surveillance against such tumors seems relatively inefficient. We studied immune surveillance against a s.c. sarcoma expressing a characterized viral tumor antigen. Surprisingly, the tumor cells were capable of inducing a protective cytotoxic T cell response if transferred as a single-cell suspension. However, if they were transplanted as small tumor pieces, tumors readily grew. Tumor growth correlated strictly with (i) failure of tumor cells to reach the draining lymph nodes and (ii) absence of primed cytotoxic T cells. Cytotoxic T cells were not tolerant or deleted because a tumor antigen-specific cytotoxic T cell response was readily induced in lymphoid tissue by immunization with virus or with tumor cells even in the presence of large tumors. Established tumors were rejected by vaccine-induced effector T cells if effector T cells were maintained by prolonged or repetitive vaccination, but not by single-dose vaccination. Thus, in addition to several other tumor-promoting parameters, some antigenic peripheral sarcomas—and probably carcinomas—may grow not because they anergize or tolerize tumor-specific T cells, but because such tumors are immunologically dealt with as if they were in a so-called immunologically privileged site and are ignored for too long.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
Rosenberg, S. A., Spiess, P., & Lafreniere, R. (1986) · Science · doi:10.1126/science.3489291 · Cited by 1,880
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Tumor Antigens Recognized by T Lymphocytes
Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., & Van Pel, A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002005 · Cited by 1,221
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
Townsend, S. E., & Allison, J. P. (1993) · Science · doi:10.1126/science.7678351 · Cited by 1,136
Chen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE
Mackaness, G. B. (1964) · The Journal of Experimental Medicine · doi:10.1084/jem.120.1.105 · Cited by 807
A NEW ANALYSIS OF ALLOGENEIC INTERACTIONS
Lafferty, K., & Cunningham, A. (1975) · Australian Journal of Experimental Biology and Medical Science · doi:10.1038/icb.1975.3 · Cited by 556
ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS*
Old, L. J., Boyse, E. A., Clarke, D. A., & Carswell, E. A. (1962) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1962.tb26446.x · Cited by 520
Pardoll, D. M. (1998) · Nature Medicine · doi:10.1038/nm0598supp-525 · Cited by 428
Oxenius, A., Bachmann, M. F., Zinkernagel, R. M., & Hengartner, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<390::aid-immu390>3.0.co;2-o · Cited by 397
Self-citationImmunological Surveillance in Neoplasia
Burnet, F. M. (1971) · Immunological Reviews · doi:10.1111/j.1600-065x.1971.tb00461.x · Cited by 342
Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., & Ohashi, P. S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.645 · Cited by 309
Self-citationFibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs
Kündig, T. M., Bachmann, M. F., DiPaolo, C., Simard, J. J. L., Battegay, M., Lother, H., Gessner, A., Kühlcke, K., Ohashi, P. S., Hengartner, H., et al. (1995) · Science · doi:10.1126/science.7761853 · Cited by 301
Self-citationVisualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts.
Zimmerman, C., Brduscha-Riem, K., Blaser, C., Zinkernagel, R. M., & Pircher, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1367 · Cited by 250
Self-citationCross-presentation: a general mechanism for CTL immunity and tolerance
Carbone, F. R., Kurts, C., Bennett, S. R. M., Miller, J. F. A. P., & Heath, W. R. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01301-2 · Cited by 241
Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., & Schreiber, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.229 · Cited by 195
Karrer, U., Althage, A., Odermatt, B., Roberts, C. W. M., Korsmeyer, S. J., Miyawaki, S., Hengartner, H., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2157 · Cited by 186
Self-citationvan der Most, R. G., Sette, A., Oseroff, C., Alexander, J., Murali-Krishna, K., Lau, L. L., Southwood, S., Sidney, J., Chesnut, R. W., Matloubian, M., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5543 · Cited by 181
Dendritic Cells Efficiently Induce Protective Antiviral Immunity
Ludewig, B., Ehl, S., Karrer, U., Odermatt, B., Hengartner, H., & Zinkernagel, R. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3812-3818.1998 · Cited by 181
Self-citationA non-retroviral RNA virus persists in DNA form
Klenerman, P., Hengartner, H., & Zinkernagel, R. M. (1997) · Nature · doi:10.1038/36876 · Cited by 176
Self-citationPrévost-Blondel, A., Zimmermann, C., Stemmer, C., Kulmburg, P., Rosenthal, F. M., & Pircher, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2187 · Cited by 172
Manipulation of costimulatory signals to enhance antitumor T-cell responses
Allison, J. P., Hurwitz, A. A., & Leach, D. R. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80077-8 · Cited by 171
Ohashi, P. S., Oehen, S., Aichele, P., Pircher, H., Odermatt, B., Herrera, P. L., Higuchi, Y., Buerki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.5185 · Cited by 131
Self-citationOehen, S., Brduscha‐Riem, K., Oxenius, A., et al. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00089-6 · Cited by 64
Maraveyas, A., Hrouda, D., & Dalgleish, A. G. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8946-9_5 · Cited by 2
Cited by
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,602
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Cancer immunoediting from immune surveillance to immune escape
Kim, R., Emi, M., & Tanabe, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02587.x · Cited by 1,074
Metadata
- Authors
- Ochsenbein, A. F., Klenerman, P., Karrer, U., Ludewig, B., Pericin, M., Hengartner, H., & Zinkernagel, R. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-03-02
- Volume
- 96
- Issue
- 5
- Pages
- 2233-2238
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2090177390
- Cited by
- 453
- References
- 28
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.